Sjöblom, A., Stenman, U., Hagström, J., Jouhi, L., Haglund, C., Syrjänen, S., . . . Carpén, T. (2021). Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status. Cancers (Basel).
Citação norma ChicagoSjöblom, Anni, Ulf-Håkan Stenman, Jaana Hagström, Lauri Jouhi, Caj Haglund, Stina Syrjänen, Petri Mattila, Antti Mäkitie, and Timo Carpén. "Tumor-Associated Trypsin Inhibitor (TATI) As a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status." Cancers (Basel) 2021.
Citação norma MLASjöblom, Anni, et al. "Tumor-Associated Trypsin Inhibitor (TATI) As a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status." Cancers (Basel) 2021.